Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

Sanofi starts work on ‘largest African facility’

September 30, 2013
Manufacturing and Production, Sales and Marketing Africa, Sanofi, algeria

Sanofi has started construction of a €70 million manufacturing facility in Algeria that will be the company’s largest site in …

News
Avastin packshot

UK pharma teams up for better cancer drug access

September 20, 2013
Medical Communications, Sales and Marketing Cancer Drugs Fund, NICE, Novartis, Roche, Sanofi, avastin, no

News
nice_sign

NICE: we need more Aubagio data

September 18, 2013
Sales and Marketing Aubagio, Genzyme, MS, NICE, Sanofi

News
sanofi_chris_viehbacher

Sanofi’s Lemtrada given European go ahead

September 18, 2013
Research and Development, Sales and Marketing Aubagio, Lemtrada, MS, Sanofi, gilenya

News
Sanofi image

Sanofi withdraws lixisenatide US application

September 12, 2013
Sales and Marketing FDA, Lixisenatide, Sanofi, diabetes, elixa

In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …

News
China image

China may be trying to ‘frighten’ pharma

September 6, 2013
Medical Communications, Sales and Marketing China, GSK, Sanofi, bribery

Western pharma companies caught up in Chinese probes over corruption are being discriminated against, according to a European business lobby …

News
Aubagio image

Aubagio approved in Europe

September 3, 2013
Sales and Marketing Aubagio, Genzyme, Rebif, Sanofi, tecfidera

Sanofi’s once-daily multiple sclerosis pill Aubagio has been authorised by European regulators, paving the way for it to continue its …

News
lilly_outside_plaque

Lilly drawn into China bribery scandal

August 22, 2013
Medical Communications, Sales and Marketing China, GSK, Sanofi, bribery, corruption, lilly, payments

News
alegtacsoweb

Algeta appoints Dr Andreas Menrad as chief scientific officer

August 19, 2013
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Algeta, Genzyme, Sanofi

Appointment
GSK China

Bribery ‘routine’ for pharma in China

August 13, 2013
Sales and Marketing BBC, China, GSK, Sanofi, bribery, drug reps

News
Sanofi HQ

Sanofi ‘co-operating’ with China bribery case

August 12, 2013
Medical Communications, Sales and Marketing China, Drug pricing, GSK, Sanofi, bribery

News
carsten_hellmann_sanofi

Sanofi makes two new senior hires

August 2, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi

Sanofi has announced the appointments of Carsten Hellmann and David Meeker to its executive committee team. Hellmann (pictured) joins Sanofi …

Appointment
Sanofi image

Sanofi sales slide on patent cliff woes

August 1, 2013
Sales and Marketing Aprovel, Plavix, Q2, Sanofi

Sanofi has been hit by generic erosion for key drugs in the second quarter, but the firm is confident it …

News
Genzyme image

Sanofi’s Lemtrada nears EU approval

July 1, 2013
Sales and Marketing CHMP, Genzyme, Lemtrada, Sanofi

Sanofi’s multiple sclerosis drug Lemtrada has received a positive recommendation from the CHMP, meaning a European approval is likely just …

News
Sanofi image

Sanofi chief executive to lead EFPIA

June 26, 2013
Research and Development, Sales and Marketing EFPIA, GSK, Sanofi, Viehbacher, Witty

Chief executive of Sanofi Christopher Viehbacher has been elected to serve as president of the European Federation of Pharmaceutical Industries …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025